Outcome of Board Meeting
Bliss GVS Pharma Limited - Earnings Presentation - Q3-F.Y.- 201820-01-2018
20-01-2018
Financial Result For The Quarter And Nine Months Ended 31/12/2017.
Financial Result & Limited Review Report19-01-2018
Meeting Updates
INTIMATION OF THE BOARD MEETING HELD ON FRIDAY, JANUARY 19, 2018 WILL BE AT 3.30 P.M. INSTEAD OF 12.00 P.M.18-01-2018
Shareholding for the Period Ended December 31, 2017
Bliss GVS Pharma Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2017. For more details, kindly Click here14-01-2018
STATEMENT OF GRIEVANCE REDRESSAL MECHANISM FOR THE QUARTER ENDED 31ST DECEMBER, 2017
STATEMENT OF INVESTOR COMPLAINTS12-01-2018
Publication Of News Paper Advertisement Of Board Meeting Intimation To Be Held On 11/01/2018
INTIMATION BY THE COMPANY PURSUANT TO REGULATION 47 OF SEBI (LISTING OBLIGATIONS & DISCLOSURE REQUIREMENTS), REGULATIONS 201506-01-2018
Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2017
This is to inform you that the Board Meeting of the Company was held today i.e. November 30, 2017 at the registered office of the Company at 04.00 p.m. The Board considered and approved the following: 1) Pursuant to Regulation 33 of SEBI (Listing Obligation and Disclosures Requirements) Regulations, 2015 the Unaudited Standalone and Consolidated Financial Results for quarter and half year ended September 30, 2017;...30-11-2017
Board Meeting On November 30, 2017
Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board Meeting of the Company will be held on Thursday, November 30, 2017 at the registered office of the Company at 4.00 p.m. to consider inter alia, the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter & half year ended September 30, 2017....22-11-2017